Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5198865
Max Phase: Preclinical
Molecular Formula: C48H77NO13
Molecular Weight: 876.14
Associated Items:
ID: ALA5198865
Max Phase: Preclinical
Molecular Formula: C48H77NO13
Molecular Weight: 876.14
Associated Items:
Canonical SMILES: CCCCC/C=C\C/C=C\CCCCCCC(=O)N[C@H]1[C@H](OC(=O)CCC(=O)O)O[C@H](CO)[C@@H](OC(=O)CCC(=O)O)[C@@H]1OC(=O)CCCCCC/C=C\C/C=C\CCCCC
Standard InChI: InChI=1S/C48H77NO13/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-39(51)49-45-47(61-42(56)32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)46(60-43(57)35-33-40(52)53)38(37-50)59-48(45)62-44(58)36-34-41(54)55/h11-14,17-20,38,45-48,50H,3-10,15-16,21-37H2,1-2H3,(H,49,51)(H,52,53)(H,54,55)/b13-11-,14-12-,19-17-,20-18-/t38-,45-,46-,47-,48+/m1/s1
Standard InChI Key: QJLKKEIUZTVIAT-GSRZTJPPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 876.14 | Molecular Weight (Monoisotopic): 875.5395 | AlogP: 9.13 | #Rotatable Bonds: 37 |
Polar Surface Area: 212.06 | Molecular Species: ACID | HBA: 11 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.36 | CX Basic pKa: | CX LogP: 10.15 | CX LogD: 3.51 |
Aromatic Rings: 0 | Heavy Atoms: 62 | QED Weighted: 0.02 | Np Likeness Score: 0.76 |
1. Zhang Y, Liang X, Bao X, Xiao W, Chen G.. (2022) Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective., 235 [PMID:35307617] [10.1016/j.ejmech.2022.114291] |
Source(1):